During a recent appearance on 98.5 The Sports Hub, Joe Mazzulla discussed the importance of the Celtics roster sticking ...

During a recent appearance on 98.5 The Sports Hub, Chris Gasper of The Boston Globe shared his concerns, noting how he 'doesn ...

UNC’s (12-8, 5-3 ACC) next test will come Saturday, January 25 at 2:15 p.m., with the Boston College Eagles making a trip to ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

The Los Angeles Clippers continue their homestand against the number two seed in the Eastern Conference, the Boston Celtics.

Boston will need to be vigilant that old habits vs. banged-up and lesser ball clubs don't make a winnable game into a ...

Boston’s starting five is finding cohesion, and its defense stifled Golden State. The Celtics’ ability to stay consistent ...

Barclays raised the firm’s price target on Boston Scientific (BSX) to $111 from $86 and keeps an Overweight rating on the shares. The firm says ...

On Nov. 22, the FDA approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer ...

The Golden State Warriors are hosting the Boston Celtics in game two of their regular season series matchup today at the ...

Syracuse hit the road to take on Boston College at Conte Forum, but struggled in the 41 point loss to the Eagles on Sunday.

TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...